Kainos Medicine Inc (284620) — Strategic Asset Allocation Index
Kainos Medicine Inc (284620) has a Strategic Asset Allocation Index of 8.5% as of March 2025. Strategic assets (PP&E of ₩456.62 Million plus long-term investments of ₩-) total ₩456.62 Million, measured against net assets of ₩5.40 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 284620 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Kainos Medicine Inc Strategic Asset Allocation Index (2020–2024)
This chart shows how Kainos Medicine Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of March 2025, the index stands at 8.5%, representing strategic assets of ₩456.62 Million against net assets of ₩5.40 Billion KRW. See 284620 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Kainos Medicine Inc (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Kainos Medicine Inc from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Kainos Medicine Inc.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 33.7% | ₩602.75 Million | ₩602.75 Million | ₩- | ₩1.79 Billion | ▲ +26.3 pp |
| 2023 | 7.5% | ₩875.47 Million | ₩875.47 Million | ₩- | ₩11.75 Billion | ▼ -13.4 pp |
| 2022 | 20.8% | ₩5.44 Billion | ₩5.44 Billion | ₩- | ₩26.11 Billion | ▼ -6.7 pp |
| 2021 | 27.5% | ₩3.33 Billion | ₩3.33 Billion | ₩- | ₩12.10 Billion | ▲ +12.6 pp |
| 2020 | 15.0% | ₩1.85 Billion | ₩1.85 Billion | ₩- | ₩12.35 Billion | — |